Genetic and Molecular Mechanisms of Common Cardiovascular Disorders: From Genes to Patients
Project List:
Coordination office
Inflammation and Immune Response in the Pathogenesis of Type2 Diabetes and Atherosclerosis: Testing the Common Soil Hypothesis
Comparative genomics of left ventricular hypertrophy and dysfunction in hypertension
Functional genomics of cardiac damage in hypertension
Functional genomics of vascular damage in hypertension
Genome-wide assessment of siblings with myocardial infarction
Identification of genes for monogenic forms of myocardial infarction
Genetics of coronary morphology
Prevalence of titin mutations and identification of novel disease genes in patients with familial Dilated Cardiomyopathy-II
Zebrafish mutants as a model for human cardiomyopathies
Identification and characterization of molecular pathways in the pathogenesis of cardiomyopathies
Contribution of genetic variation in modifier genes to cardiomyopathy phenotypes
Identification of genetic modifiers of cardiomyopathy in mice
Genomic predictors of heart failure following anthracycline cancer therapy
Genomics of diastolic heart failure: susceptibility, progression and therapeutic outcome
SMP-GEM heart failure
Population genetics of cardiovascular diseases
Functional in vivo evaluation of novel cardiovascular genes by antisense oligonucleotide-mediated gene knock-down in zebrafish embryos
Genotype-phenotype association studies in clinically well-characterised patients with inherited bleeding disorders
Von Willebrand Factor in haemorrhagic and thrombotic disorders
Inflammation and Immune Response in the Pathogenesis of Type2 Diabetes and Atherosclerosis: Testing the Common Soil Hypothesis
Comparative genomics of left ventricular hypertrophy and dysfunction in hypertension
Functional genomics of cardiac damage in hypertension
Functional genomics of vascular damage in hypertension
Genome-wide assessment of siblings with myocardial infarction
Identification of genes for monogenic forms of myocardial infarction
Genetics of coronary morphology
Prevalence of titin mutations and identification of novel disease genes in patients with familial Dilated Cardiomyopathy-II
Zebrafish mutants as a model for human cardiomyopathies
Identification and characterization of molecular pathways in the pathogenesis of cardiomyopathies
Contribution of genetic variation in modifier genes to cardiomyopathy phenotypes
Identification of genetic modifiers of cardiomyopathy in mice
Genomic predictors of heart failure following anthracycline cancer therapy
Genomics of diastolic heart failure: susceptibility, progression and therapeutic outcome
SMP-GEM heart failure
Population genetics of cardiovascular diseases
Functional in vivo evaluation of novel cardiovascular genes by antisense oligonucleotide-mediated gene knock-down in zebrafish embryos
Genotype-phenotype association studies in clinically well-characterised patients with inherited bleeding disorders
Von Willebrand Factor in haemorrhagic and thrombotic disorders